Search results for "enzyme inhibitors"

showing 10 items of 559 documents

Involvement of PKC and NF-κB in Nitric Oxide Induced Apoptosis in Human Coronary Artery Smooth Muscle Cells

2001

Apoptosis of vascular smooth muscle cells is critically involved in progression of atherosclerosis and may prevent intimal hyperplasia in restenosis and vascular remodeling. Nitric oxide (NO) is known to induce apoptosis, but the signaling pathways still remain unclear. We investigated p53 accumulation, protein kinase C (PKC) activation and nuclear transcription factor (NF-kappaB) binding activity as possible signaling mechanisms of NO-induced apoptosis. Apoptosis was induced dose-dependently with the NO-donors sodiumnitroprusside (SNP: 232+/-48%) and SIN-1 (241+/-90% of actinomycin D induced apoptosis; means +/- SEM, *por =0.05 vs. control) in HSMC. Inhibition of PKC significantly attenuat…

Nitroprussidemedicine.medical_specialtyVascular smooth muscleIntimal hyperplasiaPhysiologyApoptosisDNA FragmentationNaphthalenesNitric OxideMuscle Smooth VascularNitric oxidechemistry.chemical_compoundNF-KappaB Inhibitor alphaRestenosisInternal medicinemedicineHumansNitric Oxide DonorsEnzyme InhibitorsCells CulturedProtein Kinase CProtein kinase CCell Nucleusbusiness.industryNF-kappa BNF-κBStaurosporinemedicine.diseaseCoronary VesselsDNA-Binding Proteinsmedicine.anatomical_structurechemistryApoptosisMolsidomineCancer researchCardiologyI-kappa B ProteinsTumor Suppressor Protein p53businessArteryCellular Physiology and Biochemistry
researchProduct

Expression and inducibility of drug-metabolizing enzymes in preneoplastic and neoplastic lesions of rat liver during nitrosamine-induced hepatocarcin…

1987

The expression, inducibility, and regulation of four different cytochrome (cyt.) P-450 isoenzymes (PB1, PB2, MC1, and MC2) NADPH-cytochrome P-450 reductase, the glutathione transferases (GSTs) B and C and microsomal epoxide hydrolase (mEHb) have been studied during nitrosamine-induced hepatocarcinogenesis using immunohistochemical techniques. The investigations revealed basic differences in the expression of the individual drug metabolizing enzymes in the course of neoplastic development. While the two GSTs and mEHb were increased in all preneoplastic and benign neoplastic lesions, the levels of the distinct cyt. P-450 isoenzymes were characteristically different from each other. Following …

NitrosaminesCytochromeHealth Toxicology and MutagenesisReductaseToxicologyenvironment and public healthIsozymeMixed Function Oxygenaseschemistry.chemical_compoundLiver Neoplasms ExperimentalCytochrome P-450 Enzyme SystemAnimalsCytochrome P-450 Enzyme InhibitorsAdenosine Triphosphataseschemistry.chemical_classificationbiologyHistocytochemistryImmunochemistryProteinsRats Inbred StrainsGeneral MedicineMolecular biologyRatsenzymes and coenzymes (carbohydrates)Drug metabolizing enzymesEnzymeLiverchemistryBiochemistryNitrosamineEnzyme InductionMicrosomal epoxide hydrolaseembryonic structurescardiovascular systembiology.proteinImmunohistochemistryFemalePrecancerous ConditionsArchives of Toxicology
researchProduct

Extracellular calcium-sensing receptor mediates human bronchial epithelial wound repair

2010

The airway epithelium routinely undergoes damage that requires repair to restore epithelial barrier integrity. Cell migration followed by proliferation are necessary steps to achieve epithelial repair. Calcium-sensing receptor (CaSR) is implicated in cell migration and proliferation processes. Thus we hypothesized that CaSR mediates lung epithelial wound repair. We detected CaSR expression in human lung and in well-differentiated human bronchial epithelial cells (HBEC). To test the CaSR functionality, HBEC loaded with fura-2 were stimulated with extracellular Ca(2+) ([Ca(2+)](out)) which resulted in a concentration-dependent intracellular Ca(2+) ([Ca(2+)](i)) increase (potency approximately…

Pathologymedicine.medical_specialtyBronchiBiologyBiochemistryCell MovementmedicineExtracellularHumansCalcium SignalingEnzyme InhibitorsEstrenesReceptorEgtazic AcidCell ProliferationPharmacologyWound HealingPhospholipase CCell growthEpithelial CellsCell migrationPyrrolidinonesEpitheliumCell biologymedicine.anatomical_structureRespiratory epitheliumCalciumCalcium-sensing receptorFura-2Receptors Calcium-SensingBiochemical Pharmacology
researchProduct

Chromoendoscopy and Other Novel Imaging Techniques

2006

The newly developed high-resolution and magnification endoscopes offer features that allow more and new mucosal details to be seen. They are commonly used in conjunction with chromoendoscopy. The analysis of mucosal surface details is beginning to resemble histologic examination. More accurate recognition of small flat and depressed neoplastic lesions is possible. Endoscopic prediction of neoplastic and nonneoplastic tissue is possible by analysis of surface architecture of the mucosa, which influences the endoscopic management. For the diagnosis of flat adenomas, chromoendoscopy should be a part of the endoscopist's armamentarium. In inflammatory bowel disease, chromoendoscopy can be used …

Pathologymedicine.medical_specialtyColonoscopyMagnificationEndoscopic managementSensitivity and SpecificityMagnifying chromoendoscopyChromoendoscopyEndomicroscopymedicineHumansEnzyme InhibitorsClinical Trials as TopicIntraepithelial neoplasiaMicroscopy ConfocalStaining and Labelingmedicine.diagnostic_testbusiness.industryGastroenterologyColonoscopyImage EnhancementMethylene BlueChromogenic CompoundsColitis UlcerativeSurveillance colonoscopybusinessPrecancerous ConditionsTomography Optical CoherenceGastroenterology Clinics of North America
researchProduct

Role of Nitric Oxide in Gastrointestinal Inflammatory and Ulcerative Diseases: Perspective for Drugs Development

2001

Nitric oxide is a ubiquitous molecule involved in a variety of biological processes. The specific action of NO depends on its enzymatic sources namely neuronal nitric oxide synthase (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) and all three isoforms have been localized in the gastrointestinal tract. Constitutive synthesis of NO by nNOS or eNOS isoforms is involved in the maintaining of the gastrointestinal mucosal integrity through modulation of gastric mucosal blood flow, epithelial secretion and barrier function. However, large amounts of NO synthesized from the inducible isoform have been implicated in tissue injury in the gut during inflammatory reactions. In this review we p…

Peptic UlcerNitric Oxide Synthase Type IIPharmacologyNitric OxideEndothelial NOSNitric oxidechemistry.chemical_compoundGastrointestinal AgentsEnosDrug DiscoverymedicineAnimalsHumansNitric Oxide DonorsEnzyme InhibitorsBarrier functionPharmacologyGastrointestinal tractbiologyAnti-Ulcer Agentsbiology.organism_classificationEpitheliumGastroenteritisNitric oxide synthasemedicine.anatomical_structureMechanism of actionchemistryImmunologybiology.proteinNitric Oxide Synthasemedicine.symptomCurrent Pharmaceutical Design
researchProduct

Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate

1999

The basic mechanism(s) by which peroxisome proliferators activate peroxisome proliferator-activated receptors (PPARs) is (are) not yet fully understood. Given the diversity of peroxisome proliferators, several hypotheses of activation have been proposed. Among them is the notion that peroxisome proliferators could activate PPARs by changing their phosphorylation status. In fact, it is well known that several members of the nuclear hormone receptor superfamily are regulated by phosphorylation. In this report, we show that the rat Fao hepatic-derived cell line, known to respond to peroxisome proliferators, exhibited a high content of PPARalpha. Alkaline phosphatase treatment of Fao cell lysat…

Peroxisome proliferator-activated receptor gammaPhosphataseReceptors Cytoplasmic and NuclearPeroxisome proliferator-activated receptorBiologyMicrobodiesBiochemistryCell LineClofibric AcidmedicineAnimalsEnzyme InhibitorsPhosphorylationPharmacologychemistry.chemical_classificationFibric Acidsfood and beveragesPeroxisomePhosphoric Monoester HydrolasesRatsGene Expression RegulationBiochemistryNuclear receptorchemistryPhosphorylationPeroxisome Proliferatorslipids (amino acids peptides and proteins)Acyl-CoA OxidasePeroxisome proliferator-activated receptor alphaCiprofibrateOxidoreductasesTranscription Factorsmedicine.drugBiochemical Pharmacology
researchProduct

COX-2 and sPLA2 inhibitory activity of aqueous extract and polyphenols of Rhizophora mangle (red mangrove)

2006

The aqueous extract of Rhizophora mangle bark and its polyphenolic fractions showed remarkable in vitro antiinflammatory activity in a preliminary study. The low molecular weight fraction exhibited cyclooxygenase-2 inhibitory activity while the total aqueous extract and the low molecular weight fraction showed secretory phospholipase A(2) inhibitory activity.

PharmacognosyPhospholipases Alaw.inventionchemistry.chemical_compoundPhenolslawDrug DiscoveryPlant BarkHumansPhenolsEnzyme InhibitorsRhizophora mangleFlavonoidsPharmacologyCyclooxygenase 2 InhibitorsDose-Response Relationship DrugTraditional medicinebiologyPlant ExtractsChemistryMembrane ProteinsPolyphenolsRhizophoraceaeGeneral Medicinebiology.organism_classificationCyclooxygenase 2Polyphenolvisual_artPlant Barkvisual_art.visual_art_mediumRhizophoraceaeBarkPhytotherapyPhytotherapyFitoterapia
researchProduct

An update on metabolism studies using human hepatocytes in primary culture

2008

Background: Cultured human hepatocytes are the closest in vitro model to human liver and constitute a very predictive model for drug metabolism in vivo. The variability observed in human hepatocytes reflects the existing phenotypic heterogeneity of cytochrome P450 expression in human liver. Objectives: As drug metabolism is the major source of pharmacokinetic variability in human beings, the main areas of current drug metabolism research in human hepatocytes are reviewed. Methods: To speed up the selection of drug candidates, the evaluation of metabolic stability, metabolite profiling and identification, and drug–drug interaction potential are key issues in drug development. Results/conclus…

PharmacologyDrugbiologyMechanism (biology)media_common.quotation_subjectCytochrome P450General MedicinePharmacologyToxicologyIn vitroCytochrome P-450 Enzyme SystemPharmaceutical PreparationsPharmacokineticsDrug developmentIn vivoEnzyme InductionHepatocytesbiology.proteinAnimalsCytochrome P-450 Enzyme InhibitorsHumansEnzyme InhibitorsCells CulturedDrug metabolismmedia_commonExpert Opinion on Drug Metabolism & Toxicology
researchProduct

Prediction of tyrosinase inhibition activity using atom-based bilinear indices.

2007

A set of novel atom-based molecular fingerprints is proposed based on a bilinear map similar to that defined in linear algebra. These molecular descriptors (MDs) are proposed as a new means of molecular parametrization easily calculated from 2D molecular information. The nonstochastic and stochastic molecular indices match molecular structure provided by molecular topology by using the kth nonstochastic and stochastic graph-theoretical electronic-density matrices, M(k) and S(k), respectively. Thus, the kth nonstochastic and stochastic bilinear indices are calculated using M(k) and S(k) as matrix operators of bilinear transformations. Chemical information is coded by using different pair com…

PharmacologyMelaninsQuantitative structure–activity relationshipStochastic ProcessesSeries (mathematics)Molecular StructureChemistryMonophenol MonooxygenaseOrganic ChemistryBilinear interpolationLinear discriminant analysisBiochemistryStructure-Activity RelationshipDiscriminantModels ChemicalComputational chemistryMolecular descriptorDrug DiscoveryLinear algebraMolecular MedicineComputer SimulationGeneral Pharmacology Toxicology and PharmaceuticsBilinear mapEnzyme InhibitorsBiological systemChemMedChem
researchProduct

Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism

2003

Drug metabolism is the major determinant of drug clearance and, because of polymorphic or inducible expression of drug-metabolising cytochrome P450s (CYPs), is the factor most frequently responsible for interindividual differences in pharmacokinetics. A number of well characterised CYP substrates and inhibitors have been identified that allow precise measurements of individual CYP isoforms. Their use, alone or in combination, facilitates the phenotype characterisation of hepatocytes in vitro and in vivo. Two procedures are used for in vitro investigation of the metabolic profile of a drug: incubation with microsomes and incubation with metabolically competent cells. The major limitation of …

PharmacologybiologyCytochrome P450In Vitro TechniquesIsozymeIn vitroRatsCytochrome P-450 Enzyme SystemPharmaceutical PreparationsBiochemistryIn vivoMolecular Probesbiology.proteinMicrosomeAnimalsCytochrome P-450 Enzyme InhibitorsHumansDrug InteractionsPharmacology (medical)Enzyme InhibitorsEnzyme inducerAntibodies BlockingCytochrome P-450 Enzyme InhibitorsDrug metabolismClinical Pharmacokinetics
researchProduct